This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Krentz, A. J Articles by Shearman, C. P Search for Related Content Social Bookmarking                         What's this?

Review: Peripheral arterial disease in diabetes: time for a co-ordinated approach to management

Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK, a.j.krentz{at}soton.ac.uk

Raj Mani

Cliff P Shearman

Peripheral arterial disease (PAD) is a major manifestation of systemic atherosclerosis. A close association between PAD and diabetes mellitus has long been recognised. Substantial morbidity results from PAD-related intermittent claudication, ulceration and critical limb ischaemia, culminating for some patients in limb loss or death. While effective lifestyle and pharmacological treatments are available for intermittent claudication these approaches are widely underutilised. Surgical intervention is indicated in relatively few patients with stable intermittent claudication. However, the high risk of premature death from the consequences of generalised atherosclerosis, notably coronary heart disease, mandates identification and treatment of modifiable cardiovascular risk factors. Sub-optimal management of cardiovascular risk in patients with PAD may reflect disparate and poorly co-ordinated care. Among patients with diabetes, PAD poses additional dangers, arterial insufficiency being a major, and possibly underestimated, component of diabetic foot disease. The combination of PAD and diabetic neuropathy is common, particularly in the elderly, resulting in impaired infection control and delayed healing of foot ulcers. PAD may also cause ischaemic ulcers. The contribution of PAD to duration of hospitalisation and longer-term clinical outcomes remains uncertain. There appears to be scope for improving the efficiency of clinical care for patients with PAD. A co-ordinated multi-disciplinary approach is required to deliver optimal care to these patients. Modifiable cardiovascular risk factors should be identified and treated. Deficiencies in podiatry and related services in the UK need to be addressed.

Key Words: peripheral arterial disease • diabetes mellitus • claudication • diabetic foot disease.

References

• Criqui MH, Fronek A., Barrett-Connor E. et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985;71:510-15.[Abstract/Free Full Text]
• Fowkes FGR. Epidemiology of atherosclerotic arterial disease in the lower limbs. Eur J Vasc Surg 1988;2:283-91.[CrossRef][Medline] [Order article via Infotrieve]
• Hiatt WR Treatment of peripheral arterial disease and claudication. N Engl J Med 2001;344:1608-21.[Free Full Text]
• Novo S. Classification, epidemiology, risk factors, and natural history of peripheral arterial disease. Diabetes Obes Metabol 2002;4(suppl 2):S1-S6.[CrossRef]
• Hiatt WR, Hoag S., Hamman RF Effect of diagnostic criteria on the prevalence of peripheral arterial disease. Circulation 1995;91:1472-9.[Abstract/Free Full Text]
• Newman AB, Sidcock DS, Manono TA et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study (CHS) Collaborative Research Group. Circulation 1993;88:837-45.[Abstract/Free Full Text]
• Westerndorp ICD, int'Veld BA, Grobbee DE et al. Hormone replacement therapy and peripheral arterial disease. Arch Intern Med 2000;160:2498-502.[Abstract/Free Full Text]
• Criqui MH, Lange RD, Fronek A. et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-6.[Abstract]
• Newman AB, Shemanski L., Manolio TA et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study (CHS) Collaborative Research Group. Arterioscler Thromb Vasc Biol 1999;19:538-45.[Abstract/Free Full Text]
• Anonymous. Managing peripheral arterial disease in primary care. DTB 2002;40:5-8.[Abstract/Free Full Text]
• European Arterial Risk Policy Group. A strategy for arterial risk assessment and management in type 2 (non-insulin-dependent) diabetes mellitus. Diabet Med 1997;14:611-21.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Scottish Intercollegiate Guidelines Network. Drug therapy for peripheral vascular disease. Edinburgh, SIGN publication number 27, 1998.
• Dormandy JA, Rutherford RB Management of peripheral vascular disease (PAD). J Vasc Surg 2000;31(suppl):S1-S296.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Caprie Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at high risk of ischaemic events. Lancet 1996;348:1329-39.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• The Heart Outcome Prevention Evaluation study investigators. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med 2000;342:145-53.[Abstract/Free Full Text]
• Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001;358:1305-15.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Heart Protection Study. Data presented at the American Heart Association, November 2001.
• McDermott MM, Mehta S., Ann H. et al. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 1997;12:209-15.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hirsch AT, Hiatt WR, Criqui MH et al. PARTNERS: A National Survey of Peripheral Arterial Disease (PAD) Symptoms and Treatment Intensity. Presented at the American College of Cardiology 50th Annual Scientific Session. Orlando, March 2001.
• UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Adler AI, Stevens RJ, Neil A. et al. for the UK Prospective Diabetes Study Group. UKPDS 59: Hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 2002;25:894-9.[Abstract/Free Full Text]
• Haffner SM The importance of hyperglycemia in the non-fasting state to the development of cardiovascular disease. Endocr Rev 1998;19:583-92.[Abstract/Free Full Text]
• Uutisupa MIJ, Niskanen LK, Siitonen O., Voutilainen E., Pyorala K. 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and non-diabetic subjects. Circulation 1990;82:27-36.[Abstract/Free Full Text]
• Schoonjans Auwerx J. Thiazolidinediones: an update. Lancet 2000; 355:1008-10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kaplan F., Al-Majali K., Betteridge DJ PPARs, insulin resistance and type 2 diabetes. J Cardiovasc Risk 2001;8:211-17.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Howlett HCS, Bailey CJ A risk-benefit assessment of metformin in type 2 diabetes mellitus. In: Krentz AJ (ed.). Drug Treatment of Type 2 Diabetes. Auckland: Adis books, 61-76.
• Gardner AW, Poehlman ET Exercise rehabilitation programmes for the treatment of claudication pain: a meta-analysis. JAMA 1995;274:975-80.[Abstract/Free Full Text]
• Davies A. The practical management of claudication. BMJ 2000;321: 911-12.[Free Full Text]
• Hittel N., Donnelly R. Treating peripheral arterial disease in patients with diabetes. Diabetes Obes Metabol 2002;4(suppl 2):S26-S31.[CrossRef]
• Woelfle KD, Lamge G., Mayer H., Bruijnen H., Lioprecht H. Distal vein grafting reconstruction for isolated tibioperoneal vessel occlusive disease in diabetics with critical limb ischaemia. Does it work? Eur J Vasc Surg 1993;7:409-13.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Donnelly R., Yeung JMC.Therapeutic angiogenesis: a step forward in intermittent claudication. Lancet 2002;339:2048-50.
• Lederman RJ, Mendelsohn FO, Anderson RD et al. for the TRAFFIC investigators. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 2002;359:2053-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Boulton AJ Foot problems in patients with diabetes mellitus. In: Williams G, Pickup JC. Textbook of Diabetes. Oxford: Blackwell Science, 1997;58:1-20.
• Krentz AJ, Acheson P., Basu A. et al. Morbidity and mortality associated with diabetic foot disease: a 12-month prospective survey of hospital admissions in a single UK centre. The Foot 1997;7:144-7.[CrossRef]
• Edmonds ME, Foster AVM. Managing the Diabetic Foot. Oxford: Blackwell Science, 2000.
• Boulton A., Buckingham T., Every N. et al. Saint Vincent Specialist Workgroups. Report of the Diabetic Foot and Amputation Group. Diabet Med 1996;13(suppl 4):S27-S42.[Web of Science][Medline] [Order article via Infotrieve]
• Effective Health Care Bulletin. Complications of Diabetes: Management of Foot Ulcers. NHS Centre for Reviews and Dissemination. University of York, 1999.
• Sumpio BE Foot ulcers. N Engl J Med 2000;343:787-93.[Free Full Text]
• Mason J., O'Keeffe C., McIntosh A., Hutchinson A., Booth A., Young RJ A systematic review of foot ulcer in patients with type 2 diabetes mellitus. I. Prevention. Diabet Med 1999;16:801-12.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Edmonds ME Progress in the care of the diabetic foot. Lancet 1999; 354:270-2.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Winocour PH, Morgan J., Ainsworth A., Williams DDR. Association of Clinical Diabetologists (ABCD) survey of specialist diabetes care services in the UK 2000. 3. Podiatry services and related foot care issues. Diabet Med 2002;19(suppl 4):32-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Tortella F., Ashleigh RJ, Bolia A., Nasim A. The management of tibial artery disease in diabetes. Br J Diabetes Vasc Dis 2002;2:162-6.[Abstract/Free Full Text]
• Foster A., Edmonds M. The National Service Framework: will it save the diabetic foot? Prac Diab Int 2002;19:127-8.[CrossRef]
• Campbell IW, Nairn M. Scottish Intercollegiate Guidelines Network: management of diabetes (SIGN 55). Br J Diabetes Vasc Dis 2002;2:50-2.[Abstract/Free Full Text]
• Hutchinson A., McIntosh A., Feder G. et al. Clinical Guidelines for Type 2 Diabetes: Prevention and Management of Foot Problems. London: Royal College of General Practitioners, 2000.
• Connor H. Diabetic foot disease - where is the evidence? Diabet Med 1999;16:799-800.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

The British Journal of Diabetes & Vascular Disease, Vol. 3, No. 2, 92-96 (2003)
DOI: 10.1177/14746514030030020301


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Kirby and R. Gardener Review: New antiplatelet guidelines for managing peripheral arterial disease -- what are the implications for diabetes? The British Journal of Diabetes & Vascular Disease, September 1, 2004; 4(5): 311 - 315. [Abstract] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Krentz, A. J Articles by Shearman, C. P Search for Related Content Social Bookmarking                         What's this?